David Jones, M.D., Professor and Director, Fetal Diagnostic Center
The Centers for Disease Control (CDC) has recently raised concerns about the effects of prescribed attention deficit hyperactivity disorder (ADHD) medication on unborn children. David Jones, M.D., director of the University of Vermont Medical Center Fetal Diagnostic Center, explains that while there is not much research on this topic, the risk of taking ADHD medication for women considering pregnancy is low. "While the data on ADHD medications is still not conclusive due to the small number of studies it appears that overall the risk of birth defects from first trimester use is minimally increased — if it is increased at all,” says Jones.
Read the full story here